Objective-To follow up known intravenous drug users to determine current health state (X2=23.81, df=2, p<0001), with a peak around 1980-3. 
Introduction
Follow up studies of and observations on drug misuse have traditionally been conducted in centres of specialised care.'1-Many have used retrospective data or followed up people by using point incidence studies of drug taking. Interest naturally centres on mortality and numbers still using various drugs after the elapse of several years or decades,6 but most studies recognise the difficulties in trying to evaluate changes in lifestyle that may have led to abstinence other than the vague notion of "maturing out" of drug use. 8 The enormous difficulties in drawing conclusions from small amounts of information have to a large extent allowed confusion to prevail in establishing effective and lasting policies for managing drug users. The need for a more profound understanding of drug use has become more evident in the late 1980s, perhaps because of HIV infection and the extension of drug injecting to the provinces and into a wider social range of people. The importance of relapse rather than remission,9 "' the need for recurrent detoxification rather than single treatments, and the establishment of damage limitation or risk reduction as a policy worth pursuing when abstinence is not likely make the need for information about lifestyles and changes in drug taking more necessary.
Critically, the realisation that drug users attending specialist clinics represent only the tip of the iceberg has highlighted throughout the 1980s the need for more information about those not attending for advice or help. In the United States particularly and to a lesser extent in Europe the decreasing distinction between hard and soft drugs and the importance of extending education to all those who might ever inject have been brought about by AIDS. In the United Kingdom recent recommendations include accepting the reality of drug use rather than forever hoping that it will go away with legislation and control." I2 The present data relate to a group of people attending a non-specialist centre (a general practice in Edinburgh) for help for a drug related problem. All were intravenous drug users and most were identified within a comparatively short time after starting to inject. Though half of them continued to attend the same general practice, the follow up study includes those currently registered elsewhere; many were contacted throughout the United Kingdom, often after many years had elapsed.
This study was therefore established not just to measure mortality as an outcome or to identify the point at which cure is present but to try to judge prognostic factors that might indicate favourable outcome and patterns of drug use. The recognition that return to drug use often happens after years of abstinence made it more interesting to concentrate on patterns of drug use and changing behaviour rather than simply on whether the subject was taking drugs.
Several things make it a unique study. It is an observation of a group in the community with no specialist care necessarily being present.'" The subjects were largely recruited early in their drug taking rather than after years of drug use"' and consequently are young compared with those in many comparable studies. Finally, they are perhaps the first cohort which has been devastated by HIV infection. The epidemiological importance of HIV in this group was examined by studying the spread in a cohort and comparing it with that in a second group who started injecting some years later.
Methods
Over six years 203 subjects known to have injected illegal drugs were recruited into a prospective study of patterns of drug taking. This cohort was closed in December 1985, and subsequent people found to be injecting drugs were recruited in the same way to another group for comparison. There All these data were coded and entered on the Edinburgh University mainframe computer and analysed using software of the statistical package for the social sciences (SPSS). Two way frequency tables were analysed by X tests for two by two tables. Groups were compared for quantitative variables by Wilcoxon rank sum tests, and Kendall rank correlation was used for testing association between quantitative variables. The relation between HIV seropositivity and year of first drug use was analysed by logistic regression, with a quadratic term being entered to fit the pattern of a peak in prevalence.
Results

FOLLOW UP COHORT
The 203 subjects recruited to the study over the six years comprised 140 men and 63 women. All had injected drugs intravenously, although two denied any such behaviour when interviewed at follow up. A total of 189 were traced by various means, 173 being interviewed and 16 having died. The remaining 14 were untraced for various reasons: four had been seen recently by their general practitioner, one was thought to be using an alias, and the remaining nine were lost because of frequent changes of address or failing to register with any services. Those lost to follow up had a mean age of 31 and all but one were men. Most had started using drugs before the peak years of HIV transmission.
The mean age of those interviewed was 29 6 years (mode 25 years); 113 (65%) were men and 60 (35%) women. In all, 151 (87%) had been born in Edinburgh and 137 (79%) were unemployed at follow up. Thirty three (19%) were married and a further 50 (29%) cohabiting; 102 (59%) had one or more children (total number of children 201). Thirty five (20%) were living with their parents. Over half (94, 54%) were still registered with this practice and were seen on the premises or at home.
The remaining 79 (46%) were traced through health board records to Scottish prisons or other general practices throughout Scotland. Six subjects were interviewed in England. Two The length of drug use was on average 7-5 years (range 1-23, mode 7 years), although the peak years for starting to use drugs were 1981 and 1982 (see figure) . The most common drugs of current use were oral dihydrocodeine and diazepam (59 and 58 of the 173 subjects respectively). Ninety three subjects (54%) took the drugs by injection at the first use. In all, 146 subjects (84%) had been tested for HIV antibodies, 94 having positive and 52 negative results; 57 of the 203 subjects had not been tested.
Abstinence (no injection of drugs for more than 12 months) was recorded in self reports from 82 subjects (47%) but was confirmed for only 33 (19%) when additional data were considered (table I). These additional data included interviews with the subjects' general practitioners, results of urine tests, and sub-BMJ VOLUME 300 27 JANUARY 1990 
The average length of drug use for the group was 5 5 years (range 1-21, mode 1 year). The most common drug currently taken was dihydrocodeine (37 subjects, 37%) followed by buprenorphine (29, 45%) and diazepam (24, 37%). Twenty nine (44%) subjects said that their first use of drugs had been injecting heroin and that they had injected drugs outside Edinburgh, while nearly half the subjects (31, 48%) said that most of their friends also used heroin and most (52, 80%) knew someone who had died of drug use.
Fifty one (79%) subjects had been tested for HIV, of whom 15 were positive for HIV antibody; a further 23 subjects were currently negative for the antibody but were reported to be still indulging in risk taking behaviour.
WHOLE COHORT (N=268)
The data in table IV show the relation between HIV seropositivity and the year when drugs were first used. Quadratic logistic regression showed that timing was highly significant (x2= 23-81, df=2, p<0 001), the peak of HIV seropositivity occurring around 1980-1.
COMPARISON OF TWO GROUPS
The data were analysed to highlight any differences or similarities between the two groups in the studythe follow up group (n= 173) and the control group of recent users (n=65).
The two groups were found to be different in terms of age, with the follow up group on average 3 2 years older (26 7 v 24-4 years; p<0001). This age difference was reflected in the average length of drug use for both groups, the follow up group having an average use of 7 5 years (range 1-23) compared with 5-5 years (range 1-21) in the more recent users (p<001). The figure shows the distribution of year of first and last use for both groups. No differences were found in the sex distribution between the two groups, women accounting for 35% (60) of the follow up group and 28% (18) of the recent users.
The choice of drugs used differed between the two groups. Recent users were significantly more likely to use buprenorphine (p<005), dihydrocodeine (p<001), and temazepam (p<0 01). All test recent users were more likely than the followed up users to have last injected heroin in 1987 and 1988. Later subjects were asked how long they had been abstinent and the date of their last intravenous injection. Recent users were significantly more likely to have a short length of abstinence (less than four weeks or one to six months) than the followed up users (two to five years, p<0001). In addition, recent users were more likely than the followed up group to mention 1987 and 1988 as the year of last injection (p<0 01). A similar proportion of subjects in both groups had been tested for HIV (84% (146) of those interviewed in the follow up cohort and 79% (51) of the recent users), but 64% (94) of the follow up cohort compared with only 29% (15) of the recent users were infected with HIV. When questioned closely about how much they had previously shared needles 89% (155) of the follow up group said that they had shared needles compared with 62% (40) of the recent users (p<0 001).
The two groups were compared to see whether any differences emerged in the type or amount of help sought for problems related to drug misuse. The results of a series of X' tests showed that the followed up cohort were more likely to have sought help from their general practitioner (p<O 10), a drug dependency unit (p<0-01), or a voluntary agency (p<0-001) and were more likely to have been in a residential establishment (p<005). They were also significantly more likely to have been in prison than the more recent group (p<005). Both groups cited their general practitioner as the most useful source of help, in fact more often than any other source (p<O 10).
Discussion
The timing of the wave of new drug users in the Edinburgh locality probably coincides with the introduction of HIV into this group quite closely and therefore suggests that the high seroprevalence may result from this coincidence. Those starting drug use during this time were additionally more likely to have shared needles, for whatever reason, further increasing the chances of infection. The previously noted high seroprevalence'4 has now been shown to be higher and may be over 80%, assuming a similar high rate in those still untested and removing the few never apparently at risk.
The comparative sparing from HIV infection of both older and younger people is interesting. Presumably needle sharing was and is less common outside these two age groups, availability partly accounting for this difference in behaviour. The older drug users had the advantage of a drug dependency unit, and the younger ones may have had the advantage of knowledge and information about AIDS. The many who are infected, as well as their cohabitants and children, are the immediate problem for all medical and social services in Edinburgh and evidently elsewhere in the United Kingdom. Although the seroprevalence may increase with time in the younger drug users, most of them have now had several tests over a prolonged period and remain negative for HIV antibody. In fact the small proportion found to be seropositive seem to be part of the larger cohort when their time of first use of drugs is considered.
Despite this the combined cohort seems otherwise to be similar to other groups studied in that older subjects are more likely to be abstinent and many subjects have episodes of abstinence and relapse. The trend towards reduced drug injecting over time may be important for planning treatment and interpreting the results of treatment. The similarities continue in the experience of drug related diseases, with the exception of HIV infection. Demographic characteristics such as employment (or lack of), socioeconomic state, and educational background are similar to those in other study groups but some findings distinguish our cohort. The subjects were generally younger than those in most studies in the United States and were mainly born and living locally. The finding that many lived with parents is of importance and again is different from many national and international studies.' It may reflect the shift of drug use towards areas of social deprivation. Those lost to follow up were largely older, which may partly explain their comparative inaccessibility. Only two were known to be positive for HIV, although the remainder had not been recently tested.
The relation between HIV testing and knowledge of HIV serostate and c^ontinued drug use was unclear. No convincing evidence was available to suggest that those who had been tested, with positive or negative results, were more or less likely to be abstinent. Many examples were found of subjects who injected more because of having a positive test result as well as those who abstained in these circumstances. Unfortunately, many examples of those who were repeatedly seronegative and continued to inject (and share equipment) are evident.
The local and national campaigns have increased since 1985, when, largely as a result of the findings in Edinburgh, drug users and by implication heterosexuals were recognised as a major risk group. In 1985 the test (HIV antibody) was made available and applied to blood transfusion donations and clinically to drug users. In 1986 a national campaign in the press, on posters, and in leaflets sent to every household was targeted at the whole population. In 1988 a national campaign targeted specifically at drug users employed similar tactics. The local network and health education activities have been intense during this time, perhaps providing more appropriate information for local consumption. It is of some interest that local workers recognise the need to constantly update and even change the message as new concerns become obvious. This particularly relates to changing drug taking patterns and the awareness of many sexual partners being at risk of HIV infection.
In all respects, therefore, this group seems to conform to expectations about mortality, morbidity (with the exception of HIV), and abstinence. HIV We thank the partners and staff of the Muirhouse Medical Group for their support and dedication in providing data and advice. The many general practitioners and family practitioner committees who now have responsibility for some of the patients were a resource without which the follow up would not have been possible. The chief scientist office of the Scottish Home and Health Department has supported the project enthusiastically for several years.
Introduction
Weighing up signs, symptoms, and test results in an individual patient, comparing them with past experience, and arriving at a reasoned decision lie at the heart of clinical medicine. Recently Spiegelhalter and Knill-Jones have proposed a simple scoring system which can add precision to risk assessment in individual patients. 14 To the non-mathematical user the great attraction of the system is that it demands only the ability to add, subtract, and look up a reference table or graph. Despite its simplicity, however, the system has a firm statistical basis and can handle complex diagnostic concepts such as conflict of evidence and doubt.' The system can be used equally well to establish prognosis or to estimate the likelihood ofa particular diagnosis (as in the original application).' This paper examines the system in relation to establishing prognosis.
The Spiegelhalter-Knill-Jones approach has been welcomed by many statisticians (see discussion after Spiegelhalter and Knill-Jones') because of the elegance with which it combines elements of Bayes's theorem with those of logistic regression. The result is a system which neatly sidesteps some of the main disadvantages of the two original techniques. For example, it does not assume that all risk factors are acting independently within each outcome class (the "independence Bayes" assumption, which is central to many bayesian analyses), while at the same time predictions are presented in a form which is less mathematical and much more clinically relevant than the output of a conventional logistic regression analysis.
We believe that the Spiegelhalter-Knill-Jones system deserves to be better known in clinical medicine, and this paper therefore focuses on the practicalities of using the technique rather than on its statistical origins. We refer to these, however, in the appendix and discussion.
Present study and results
SOURCE OF ILLUSTRATIVE DATA
All patients who served in the assessment were aged 65 or over and received a general surgical operation. They comprised 258 patients from Dundee (age range 65-93) and 299 patients from Cardiff (age range 65-97). Two thirds of the patients in both data sets were aged between 65 and 74. Full details of the patients are given elsewhere.-Many variables relating to preoperative state and postoperative outcome were collected prospectively in both data sets by using criteria established in advance and which are described elsewhere.67 As our purpose is to illustrate the Spiegelhalter-Knill-Jones approach with a simple clinical example, this paper looks simply at the ability of four preoperative risk factors (preoperative chest disease, smoking in the six weeks before admission, site of the surgical incision, and presence of volume depletion) to predict postoperative respiratory complications. Full details of how variables were defined in the larger study and of how these four respiratory variables were selected from an initial list of 19 have been reported.'-Brief definitions are given in table I.
The collection of two data sets, the first from Dundee and the second from Cardiff, was deliberate. Data collection from both data sets was completed before any calculations were performed, but the weightings on which the Spiegelhalter-Knill-Jones system is based were calculated solely from the patients from Dundee, who thus made up the "training" data set. The weightings obtained from the training data set were then applied to the Cardiff group -that is, the BMJ VOLUME 300 27 JANUARY 1990
